BioSpace News Archive

Ziopharm Oncology , Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020, at 5:00 p.m. ET. An audio webcast of the fireside chat will be available live, which can be accessed in the “Investors” section of the Ziopharm website at www.ziopharm.com . A recording of the webcast wi

Crinetics Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2020

Abbott (NYSE: ABT) announced today new research, published in the Journal of Clinical Microbiology, which found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began.

Aidoc - the leading provider of AI solutions for radiologists - announced today that the FDA has allowed the use of their cleared AI algorithms intended for adjunctive use in the detection of findings associated with COVID-19.

In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing

Outcomes presented at HRS 2020 SCIENCE demonstrate device benefits for patients at risk of sudden cardiac death

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement- Pharmacovigilance: Improving Drug Development Amid The Covid-19 Crisis

The National Eczema Association (NEA) announces the opening of its 2020 research grant cycle. As the largest private nonprofit funder of eczema research, NEA has invested over $1.4 million to date to support a deeper understanding of eczema, provide insights into new treatment strategies and improve care and prevention.

HJB, today announces that its partner Mabspace Biosciences has received Investigational New Drug (IND) clearance from both the U.S. Food and Drug Administration (FDA) and China National Medical Products Administration (NMPA), for a humanized Claudin18.2 monoclonal antibody program.

ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer’s Injection, USP.